Human mesenchymal stem cells resolve airway inflammation, hyperreactivity, and histopathology in a mouse model of occupational asthma

Stem Cells and Development

Volumn 23, Issue 19, 2014, Pages 2352-2363

  Martínez González, Itziar ^a   Cruz, Maria Jesús ^b,c   Moreno, Rafael ^a   Morell, Ferran ^b,c   Muñoz, Xavier ^b,c   Aran, Josep M ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 33 DECOY RECEPTOR SST2; INTERLEUKIN RECEPTOR; METHACHOLINE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUSCLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERPLASIA; IMMUNOGLOBULIN PRODUCTION; LUNG ALVEOLUS; LUNG INFILTRATE; LYMPHOCYTIC INFILTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MUSCLE HYPERTROPHY; NEUTROPHILIA; NONHUMAN; OCCUPATIONAL ASTHMA; RESPIRATORY TRACT ALLERGY; ANIMAL; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ANIMALS; ASTHMA, OCCUPATIONAL; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C;

EID: 84907448675     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0616     Document Type: Article

References (41)

1. Szram J and P Cullinan. (2012). Occupational asthma. Semin Respir Crit Care Med 33:653-665.
2. Moscato G and E Galdi. (2006). Asthma and hairdressers. Curr Opin Allergy Clin Immunol 6:91-95.
3. Orriols R, I Isidro, K Abu-Shams, R Costa, J Boldu, G Rego, JP Zock; other Members of the Enfermedades Re-spiratorias Ocupacionales y Medioambientales (EROM) Group. (2010). Reported occupational respiratory diseases in three Spanish regions. Am J Ind Med 53:922-930.
4. Muñoz X, MJ Cruz, R Orriols, C Bravo, M Espuga and F Morell. (2003) Occupational asthma due to persulfate salts: diagnosis and follow-up. Chest 123:2124-2129.
5. Vandenplas O, H Dressel, D Wilken, J Jamart, D Heederik, P Maestrelli, T Sigsgaard, P Henneberger and X Baur. (2011). Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J 38:804-811.
6. Rachiotis G, R Savani, A Brant, SJ MacNeill, A Newman Taylor and P Cullinan. (2007). Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 62:147-152.
7. Muñoz X, S Gómez-Ollés, MJ Cruz, MD Untoria, R Orriols and F Morell. (2008). Course of bronchial hyperresponsive-ness in patients with occupational asthma caused by exposure to persulfate salts. Arch Bronconeumol 44:140-145.
8. Prockop DJ and JY Oh. (2012). Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 20:14-20.
9. Knight DA, FM Rossi and TL Hackett. (2010). Mesench-ymal stem cells for repair of the airway epithelium in asthma. Expert Rev Respir Med 4:747-758.
10. Strioga M, S Viswanathan, A Darinskas, O Slaby and J Michalek. (2012). Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mes-enchymal stem and stromal cells. Stem Cells Dev 21:2724-2752.
11. Németh K, A Keane-Myers, JM Brown, DD Metcalfe, JD Gorham, VG Bundoc, MG Hodges, I Jelinek, S Madala, S Karpati and E Mezey. (2010). Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 107:5652-5657.
12. Sanz L, M Compt, I Guijarro-Muñoz and L Alvarez-Vallina. (2012). Nonhematopoietic stem cells as factories for in vivo therapeutic protein production. Gene Ther 19:1-7.
13. Bonfield TL, M Koloze, DP Lennon, B Zuchowski, SE Yang and AI Caplan. (2010). Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 299:L760-L770.
14. Lee SH, AS Jang, JH Kwon, SK Park, JH Won and CS Park. (2011). Mesenchymal stem cell transfer suppresses airway remodeling in a toluene diisocyanate-induced mu-rine asthma model. Allergy Asthma Immunol Res 3:205-211.
15. Mei SH, SD McCarter, Y Deng, CH Parker, WC Liles and DJ Stewart. (2007). Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4:e269.
16. De Vooght V, MJ Cruz, S Haenen, K Wijnhoven, X Mu-ñoz, PH Hoet, F Morell, B Nemery and JA Vanoirbeek. (2010). Ammonium persulfate can initiate an asthmatic response in mice. Thorax 65:252-257.
17. Martínez-González I, O Roca, JR Masclans, R Moreno, MT Salcedo, V Baekelandt, MJ Cruz, J Rello and JM Aran. (2013). Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate en-dotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 49:552-562.
18. Lloyd CM. (2010). IL-33 family members and asthma-bridging innate and adaptive immune responses. Curr Opin Immunol 22:800-806.
19. Moreno R, I Martínez, J Petriz, M Nadal, X Tintoré, JR Gonzalez, E Gratacós and JM Aran. (2011). The b-interferon scaffold attachment region confers high-level transgene expression and avoids extinction by epigenetic modifications of integrated provirus in adipose tissue-derived human mesenchymal stem cells. Tissue Eng Part C Methods 17: 275-287.
20. Ren G, X Zhao, L Zhang, J Zhang, A L'Huillier, W Ling, AI Roberts, AD Le, S Shi, C Shao and Y Shi. (2010). Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 184: 2321-2328.
21. Németh K, A Leelahavanichkul, PS Yuen, B Mayer, A Parmelee, K Doi, PG Robey, K Leelahavanichkul, BH Koller, et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49.
22. Kavanagh H and BP Mahon. (2010). Allogeneic mesen-chymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy 66:523-531.
23. Goodwin M, V Sueblinvong, P Eisenhauer, NP Ziats, L LeClair, ME Poynter, C Steele, M Rincon and DJ Weiss. (2011). Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 29:1137-1148.
24. Sun YQ, MX Deng, J He, QX Zeng, W Wen, DS Wong, HF Tse, G Xu, Q Lian, J Shi and QL Fu. (2012). Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells 30:2692-2699.
25. Abreu SC, MA Antunes, JC de Castro, MV de Oliveira, E Bandeira, DS Ornellas, BL Diaz, MM Morales, DG Xisto and PRM Rocco. (2013). Bone marrow-derived mononu-clear cells vs. mesenchymal stromal cells in experimental allergic asthma. Respir Physiol Neurobiol 187:190-198.
26. Ge X, C Bai, J Yang, G Lou, Q Li and R Chen. (2013). Effect of mesenchymal stem cells on inhibiting airway remodeling and airway inflammation in chronic asthma. J Cell Biochem 114:1595-1605.
27. Mathias LJ, SML Khong, L Spyroglou, NL Payne, C Siatskas, AN Thorburn, RL Boyd and TSP Heng. (2013). Alveolar macrophages are critical for the inhibition of allergic asthma by mesenchymal stromal cells. J Immunol 191:5914-5924.
28. Lathrop MJ, EM Brooks, NR Bonenfant, D Sokocevic, ZD Borg, M Goodwin, R Loi, F Cruz, CW Dunaway, C Steele and DJ Weiss. (2014). Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway. Stem Cells Transl Med 3:194-205.
29. Caplan AI and D Correa. (2011). The MSC: an injury drugstore. Cell Stem Cell 9:11-15.
30. Tarkowski M, JA Vanoirbeek, HM Vanhooren, V De Vooght, CM Mercier, J Ceuppens, B Nemery and PH Hoet. (2007). Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. Am J Physiol Lung Cell Mol Physiol 292:L207-L214.
31. Vanoirbeek JA, V De Vooght, HM Vanhooren, TS Nawrot, B Nemery and PH Hoet. (2008). How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice? J Allergy Clin Immunol 121: 456-463.
32. Pauluhn J. (2008). Brown Norway rat asthma model of diphenylmethane-4, 4¢-diisocyanate (MDI): analysis of the elicitation dose-response relationship. Toxicol Sci 104: 320-331.
33. Camporeale A and V Poli. (2012). IL-6, IL-17 and STAT3: a holy trinity in auto-immunity? Front Biosci 17:2306-2326.
34. Corcione A, F Benvenuto, E Ferretti, D Giunti, V Cap-piello, F Cazzanti, M Risso, F Gualandi, GL Mancardi, V Pistoia and A Uccelli. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372.
35. Park HK, KS Cho, HY Park, DH Shin, YK Kim, JS Jung, SK Park and HJ Roh. (2010). Adipose-derived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev 19:1811-1818.
36. Busse WW. (2010). The relationship of airway hyperre-sponsiveness and airway inflammation: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 138:4S-10S.
37. Lee HY, CK Rhee, JY Kang, JH Byun, JY Choi, SJ Kim, YK Kim, SS Kwon and SY Lee. (2014). Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res 40:66-76.
38. Kearley J, KF Buckland, SA Mathie and CM Lloyd. (2009). Resolution of allergic inflammation and airway hyperre-activity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 179:772-781.
39. Rocha PN, TJ Plumb, SD Crowley and TM Coffman. (2003). Effector mechanisms in transplant rejection. Immunol Rev 196:51-64.
40. Crop MJ, SS Korevaar, R de Kuiper, JNI Jzermans, NM van Besouw, CC Baan, W Weimar and MJ Hoogduijn. (2011). Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells. Cell Transplant 20:1547-1559.
41. Meyerrose TE, M Roberts, KK Ohlemiller, CA Vogler, L Wirthlin, JA Nolta and MS Sands. (2008). Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells 26:1713-1722.